|
Volumn 10, Issue 6, 2006, Pages 647-649
|
Atomoxotine treating patients with Autistic Disorder [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATOMOXETINE;
METHYLPHENIDATE;
NEUROLEPTIC AGENT;
ADRENERGIC RECEPTOR AFFECTING AGENT;
PROPYLAMINE;
ADULT;
APPETITE DISORDER;
AUTISM;
CASE REPORT;
DIZZINESS;
DROWSINESS;
DRUG INDUCED HEADACHE;
HUMAN;
HYPERACTIVITY;
INTELLIGENCE QUOTIENT;
IRRITABILITY;
LETTER;
MALE;
OBSERVATIONAL STUDY;
OUTPATIENT;
PRIORITY JOURNAL;
SIDE EFFECT;
SLEEP DISORDER;
SPEECH DISORDER;
STOMACH PAIN;
THIRST;
WECHSLER INTELLIGENCE SCALE;
ATTITUDE TO HEALTH;
BEHAVIOR DISORDER;
CHILD;
COST OF ILLNESS;
EMPATHY;
FAMILY HEALTH;
GRIEF;
INTERVIEW;
PARENT;
PSYCHOLOGICAL ASPECT;
RESIDENTIAL CARE;
RESIDENTIAL HOME;
SOCIAL ISOLATION;
ADRENERGIC UPTAKE INHIBITORS;
ATTITUDE TO HEALTH;
AUTISTIC DISORDER;
CHILD;
CHILD BEHAVIOR DISORDERS;
COST OF ILLNESS;
EMPATHY;
FAMILY HEALTH;
GRIEF;
GROUP HOMES;
HUMANS;
INTERVIEWS;
PARENTS;
PROPYLAMINES;
RESIDENTIAL TREATMENT;
SOCIAL ISOLATION;
|
EID: 33750203500
PISSN: 13623613
EISSN: 14617005
Source Type: Journal
DOI: 10.1177/1362361306073001 Document Type: Letter |
Times cited : (10)
|
References (7)
|